Changing the Paradigm in FLACS

Next Generation Femtosecond Laser is
Changing the Future of Premium Cataract Surgery

Cathleen McCabe, MD presenting at ESCRS 2022 in Milan, Italy

Request More Information

ALLY® Adaptive Cataract Treatment System

ALLY is the first FDA-cleared platform to enable cataract surgeons to complete the FLACS procedure seamlessly in a single, sterile environment. This next-gen, dual-pulse femtosecond laser increases efficiencies and drives the outcomes that premium patients expect. Request more information.


  • Reduced Procedure Times: treat more patients with a significantly faster FLACS procedure and a system that seamlessly integrates into your existing workflow.
  • Superior Surgical Workflow: designed to fit in any OR or surgery suite with a reduced footprint that improves transitions, mobility, and simplifies workflow.
  • Practice Growth: streamline your workflow to fully utilize surgical space and maximize patient throughput without compromising safety or outcomes.


  • Precision & Optimization: precise, reproductible, automatic capsulorhexis and one-touch incision planning combined with Augmented Reality™ and Cataract Density Imaging, drives an optimal laser treatment for greater confidence and potentially faster visual recovery for patients.
  • Superior Astigmatism Management: ALLY’s Streamline® IV technology consistently guides astigmatic outcomes within 0.50 D of intended target.¹⁻⁵
  • Better Experience: engineered to improve surgeon, staff, and patient experience with a seamless workflow, faster treatments, and outcomes premium patients expect.

Request More Information

Learn more about our
next-gen, dual-pulse femto.
The future of cataract surgery is here!